NASDAQ: SENS
Senseonics Holdings, Inc.
Healthcare · Medical - Devices
After hours: $7.73(0%) · as of 7:48 PM ET
Market Cap
$323.07M
52w High
$11.58
52w Low
$4.79
P/E
-3.41
Volume
780.66K
Outstanding Shares
41.79M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 19.81% over the last year. Revenue grew 90.63% over the trailing twelve months. Operating margin moved from -254.96% to -223.22%. Free cash flow declined 76.71% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -223.22%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems.
Valuation
Stock splits
Every 20 shares became 1
Profitability & growth
Analyst consensus
9
Buy
5
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 4, 2026
Q4 FY26 · EPS est -$0.48 · Revenue est $16.2M
View